Does BORTEZOMIB Cause Basal cell carcinoma? 158 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 158 reports of Basal cell carcinoma have been filed in association with BORTEZOMIB (bortezomib). This represents 0.3% of all adverse event reports for BORTEZOMIB.
158
Reports of Basal cell carcinoma with BORTEZOMIB
0.3%
of all BORTEZOMIB reports
1
Deaths
35
Hospitalizations
How Dangerous Is Basal cell carcinoma From BORTEZOMIB?
Of the 158 reports, 1 (0.6%) resulted in death, 35 (22.2%) required hospitalization, and 20 (12.7%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BORTEZOMIB. However, 158 reports have been filed with the FAERS database.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which BORTEZOMIB Alternatives Have Lower Basal cell carcinoma Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX